These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15302460)

  • 1. Pressure effects on cellular systems: is there a link with benign prostatic hyperplasia?
    Hegarty P; Watson RW; Hegarty NJ; Coffey RN; Fitzpatrick JM
    Urology; 2004 Aug; 64(2):195-200. PubMed ID: 15302460
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of growth factors in the pathogenesis of BPH.
    Habib FK
    Prog Clin Biol Res; 1994; 386():43-50. PubMed ID: 7528412
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives].
    Desgrandchamps F; Tatoud R; Cussenot O; Teillac P; Le Duc A
    Prog Urol; 1992 Dec; 2(6):1031-44. PubMed ID: 1284554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology of benign prostatic hyperplasia.
    Lee C; Kozlowski JM; Grayhack JT
    Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones and/or growth factors in prostate hypertrophy, pathophysiology and treatment.
    Mathé G
    Biomed Pharmacother; 1995; 49(7-8):317-8. PubMed ID: 8562855
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.
    Serio M; Fiorelli G
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):C77-81. PubMed ID: 1718792
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis of BPH: role of hormones.
    Griffiths K; Eaton CL
    Prog Clin Biol Res; 1994; 386():33-41. PubMed ID: 7528401
    [No Abstract]   [Full Text] [Related]  

  • 8. Common characteristics of human and canine benign prostatic hyperplasia.
    Isaacs JT
    Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology and natural history of benign prostatic hyperplasia].
    Sugimura Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():318-21. PubMed ID: 12599592
    [No Abstract]   [Full Text] [Related]  

  • 10. [Steroid substances--androgens].
    Shimazaki J; Fuse H; Akimoto S
    Nihon Rinsho; 1986 Jan; 44(1):122-9. PubMed ID: 2421025
    [No Abstract]   [Full Text] [Related]  

  • 11. [Why does the prostate grow? Possible role of growth factors for development of benign prostatic hyperplasia].
    Tørring N; Nexø E
    Ugeskr Laeger; 1997 May; 159(19):2833-5. PubMed ID: 9190708
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of stromal tissue in benign prostatic hyperplasia: morphological, immunofluorescence and endocrinological investigations.
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Stanzl U; Marth C; Daxenbichler G; Rohr HP
    Prog Clin Biol Res; 1984; 145():159-79. PubMed ID: 6201873
    [No Abstract]   [Full Text] [Related]  

  • 13. Human benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1984; 145():1-25. PubMed ID: 6201871
    [No Abstract]   [Full Text] [Related]  

  • 14. [The etiology of benign prostatic hyperplasia--recent findings].
    Lindner UA; Zisman A; Lindner A
    Harefuah; 1999 Jan; 136(2):161-4. PubMed ID: 10914188
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
    Pawlicki B; Zieliński H; Dabrowski M
    Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K
    Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal signaling in prostatic hyperplasia and neoplasia.
    Marcelli M; Cunningham GR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3463-8. PubMed ID: 10522981
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs.
    Zhang Y; He X; Chen X; Ma H; Liu D; Luo J; Du Z; Jin Y; Xiong Y; He J; Fang D; Wang K; Lawson WE; Hui JC; Zheng Z; Wu G
    Circulation; 2007 Jul; 116(5):526-34. PubMed ID: 17620513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
    Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY
    J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostatic hyperplasia in the nonhuman primate.
    Lewis RW
    Prog Clin Biol Res; 1984; 145():235-55. PubMed ID: 6201877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.